5.19
0.76%
-0.04
アフターアワーズ:
5.15
-0.04
-0.77%
Amylyx Pharmaceuticals Inc (AMLX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
18.26%
88.64
|
108.45 | 102.69 | 98.22 | 71.43 |
Cost Of Revenue |
36.49%
5.945
|
9.36 | 5.218 | 5.58 | 5.283 |
Gross Profit |
16.54%
82.70
|
99.09 | 97.47 | 92.64 | 66.14 |
Operating Expenses
|
110.83%
204.83
|
97.16 | 78.75 | 72.44 | 68.20 |
Benefits Costs and Expenses |
103.19%
207.19
|
101.97 | 80.28 | 74.21 | 70.03 |
Costs And Expenses |
97.88%
210.77
|
106.52 | 83.97 | 78.02 | 73.48 |
Operating Income/Loss |
6,415%
-122.13
|
1.934 | 18.72 | 20.20 | -2.053 |
Nonoperating Income/Loss |
21.20%
3.579
|
4.542 | 3.691 | 3.806 | 3.456 |
Income/Loss From Continuing Operations Before Tax |
1,931%
-118.55
|
6.476 | 22.41 | 24.01 | 1.403 |
Income Tax Expense/Benefit |
86.13%
0.242
|
1.745 | 1.518 | 1.933 | -0.17 |
Income/Loss From Continuing Operations After Tax |
2,611%
-118.79
|
4.731 | 20.89 | 22.07 | 1.573 |
Net Income/Loss
|
2,611%
-118.79
|
4.731 | 20.89 | 22.07 | 1.573 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
61,553%
67.85
|
0.1101 | 67.41 | 67.23 | 66.72 |
Diluted Average Shares |
44,648%
67.85
|
-0.1523 | 69.75 | 70.13 | 70.86 |
Basic Earnings Per Share |
2,600%
-1.75
|
0.07 | 0.31 | 0.33 | 0.02 |
Diluted Earnings Per Share |
2,600%
-1.75
|
0.07 | 0.30 | 0.31 | 0.02 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):